Company Overview of Kadmon Corporation, LLC
Kadmon Corporation, LLC discovers and develops therapeutic drugs based on molecular biology and genomics for the treatment of oncology, immunology, and infectious and neurodegenerative diseases. The company also distributes and markets a portfolio of branded and generic drugs for the treatment and management of hepatitis C. Its products include Ribasphere, Ribasphere RibaPak, and Syprine. Kadmon Corporation, LLC was formerly known as Kadmon Holdings, LLC. The company was incorporated in 2009 and is based in New York, New York with operations in Warrendale, Pennsylvania; Wilmington, Massachusetts; and Monmouth Junction, New Jersey.
450 East 29th Street
New York, NY 10016
Founded in 2009
Key Executives for Kadmon Corporation, LLC
Kadmon Corporation, LLC Key Developments
Similar Private Companies By Industry
|RiboNova Inc.||United States|
|Easel Biotechnologies, LLC||United States|
|Satori Pharmaceuticals Incorporated||United States|
|ADMET Technologies, Inc.||United States|
|IDM, Inc.||United States|
Recent Private Companies Transactions
October 22, 2015
To contact Kadmon Corporation, LLC, please visit www.kadmon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.